Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Journal of Parenteral and Enteral Nutrition
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Mittendorfer, B.
Right arrow Articles by Wolfe, R. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mittendorfer, B.
Right arrow Articles by Wolfe, R. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Accelerated Glutamine Synthesis in Critically III Patients Cannot Maintain Normal Intramuscular Free Glutamine Concentration

Bettina Mittendorfer, PhD

Department of Surgery. The University, of Texas Medical Branch at Galveston

Dennis C. Gore, MD

Department of Surgery. The University, of Texas Medical Branch at Galveston

David N. Herndon, MD

Department of Surgery. The University, of Texas Medical Branch at Galveston

Robert R. Wolfe, PhD

Department of Surgery. The University, of Texas Medical Branch at Galveston

Background: Muscle glutamine is severely depleted in critically ill patients (by ~50% to 80% of normal). Because muscle protein breakdown, and thus the release of glutamine from muscle protein, is enhanced in response to metabolic stress, the depletion of intramuscular glutamine could be due to its impaired synthesis or accelerated outward transport or both. Methods: To distinguish these possibilities, we measured skeletal muscle glutamine metabolism in five critically ill patients by means of primed, continuous infusions of 5-15N-glutamine and ring-2H5-phenylalanine and compared them to values we previously reported for healthy volunteers. Results: The intramuscular free glutamine concentration in patients was ~70% of that in healthy volunteers (5.8 ± 0.6 mmol/L intracellular free water vs 21.5 ± 2.8 mmol/L). Whole-body glutamine rate of appearance was 5.8 ± 1.0 µmol · kg-1 body wt · min-1, and whole-body clearance was 19.3 ± 3.3 mL · kg-1 · min-1. Despite the low intramuscular glutamine concentration in the patients, the rate of unidirectional outward transport from skeletal muscle into venous blood (1.1. ± 0.2 µmol · 100 mL · leg-1 · min-1) was similar to that observed in healthy volunteers (1.6 ± 0.2 µmol · 100 mL · leg 1 · min 1); intramuscular synthesis was 2.7 ± 0.9 µmol · 100 mL · leg-1 · min-1 compared with a normal value of 0.6 ± 0.06 µmol · 100 mL · = leg-1 · min -1. Net balance across the leg was normal. Conclusions: The depletion of intramuscular glutamine in critically ill patients is not due to an impairment of the rate of synthesis. In fact, accelerated glutamine production cannot maintain normal intramuscular glutamine levels because of accelerated outward transport. (Journal of Parenteral and Enteral Nutrition 23:243-252, 1999)

Journal of Parenteral and Enteral Nutrition, Vol. 23, No. 5, 243-252 (1999)
DOI: 10.1177/0148607199023005243


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J. Nutr.Home page
J. Wernerman
Clinical Use of Glutamine Supplementation
J. Nutr., October 1, 2008; 138(10): 2040S - 2044S.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. Y. Fram, M. G. Cree, D. L. Chinkes, D. N. Herndon, and R. R. Wolfe
Recovery of labeled CO2 from acetate in severely burned children
Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1726 - E1729.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. S. C. Raj, P. Zager, V. O. Shah, E. A. Dominic, O. Adeniyi, P. Blandon, R. Wolfe, and A. Ferrando
Protein turnover and amino acid transport kinetics in end-stage renal disease
Am J Physiol Endocrinol Metab, January 1, 2004; 286(1): E136 - E143.
[Abstract] [Full Text]


Home page
Am. J. Clin. Nutr.Home page
P. G Boelens, A. P. Houdijk, H. N de Thouars, T. Teerlink, M. I. van Engeland, H. J. Haarman, and P. A. van Leeuwen
Plasma taurine concentrations increase after enteral glutamine supplementation in trauma patients and stressed rats
Am. J. Clinical Nutrition, January 1, 2003; 77(1): 250 - 256.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
Y.-M. Yu, C. M. Ryan, Z.-W. Fei, X.-M. Lu, L. Castillo, J. T. Schultz, R. G. Tompkins, and V. R. Young
Plasma L-5-oxoproline kinetics and whole blood glutathione synthesis rates in severely burned adult humans
Am J Physiol Endocrinol Metab, February 1, 2002; 282(2): E247 - E258.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
V. R. Young and A. M. Ajami
Glutamine: The Emperor or His Clothes?
J. Nutr., September 1, 2001; 131(9): 2449S - 2459.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
P. Furst
New Developments in Glutamine Delivery
J. Nutr., September 1, 2001; 131(9): 2562S - 2568.
[Abstract] [Full Text] [PDF]